Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer

被引:45
|
作者
Li, Shiqi [1 ]
Zhu, Yi [1 ]
Liang, Zhen [1 ]
Wang, Xiao [1 ]
Meng, Shuai [1 ]
Xu, Xin [1 ]
Xu, Xianglai [1 ]
Wu, Jian [1 ]
Ji, Alin [1 ]
Hu, Zhenghui [1 ]
Lin, Yiwei [1 ]
Chen, Hong [1 ]
Mao, Yeqing [1 ]
Wang, Wei [1 ]
Zheng, Xiangyi [1 ]
Liu, Ben [1 ]
Xie, Liping [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
bladder cancer; microRNA-877-3p; p16; RNA activation; TUMOR-SUPPRESSOR GENE; TRANSCRIPTIONAL ACTIVATION; HUMAN-CELLS; MICRORNAS; RNA; EXPRESSION; COMPLEMENTARY; TRANSDUCTION; SENESCENCE; GROWTH;
D O I
10.18632/oncotarget.10575
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the recent studies which have shown that microRNA (miRNA) negatively regulates gene expression by silencing the expression of target genes, here we reported the new evidence of microRNA-mediated gene activation by targeting specific promoter sites. We identified a miR-877-3p binding site on the promoter site of tumor suppressor gene p16 which alters frequently in bladder cancer. Enforced expression of miR-877-3p could increase the expression of p16, which inhibit the proliferation and tumorigenicity of bladder cancer through cell cycle G1-phase arrest. Further evidences confirmed that the correlation between p16 activation and miR-877-3p was due to the direct binding. These findings demonstrate the anti-tumor function of miR-877-3p in bladder cancer cells and reveal a new pattern of miRNA involved gene regulation.
引用
收藏
页码:51773 / 51783
页数:11
相关论文
共 50 条
  • [31] MiR-381-3p/RAB2A axis activates cell proliferation and inhibits cell apoptosis in bladder cancer
    Sun, Xiaolu
    Hu, Xiufang
    Wang, Xiangtao
    Jiang, Xianzhou
    CELLULAR AND MOLECULAR BIOLOGY, 2020, 66 (06) : 117 - 120
  • [32] Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27kip1, p57kip2, and PUMA
    Sarkar, Shaan
    Dubaybo, Hala
    Ali, Shadan
    Goncalves, Priscila
    Kollepara, Sri Lakshmi
    Sethi, Seema
    Philip, Philip A.
    Li, Yiwei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2013, 3 (05): : 465 - 477
  • [33] miR-339-3p inhibits proliferation and metastasis of colorectal cancer
    Zhou, Chang
    Lu, Yenxia
    Li, Xuenong
    Oncology Letters, 2015, 10 (05) : 2842 - 2848
  • [34] Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4
    Yang, Dengke
    Du, Guang
    Xu, An
    Xi, Xuetao
    Li, Dong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (11): : 2209 - 2219
  • [35] MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer
    Gao, L.
    Yan, P.
    Guo, F. F.
    Liu, H. J.
    Zhao, Z. F.
    NEOPLASMA, 2018, 65 (01) : 89 - 96
  • [36] Deletion of p16 and p15 genes In schistosomiasis-associated bladder cancer (SABC)
    Eissa, S
    Ali-Labib, R
    Khalifa, A
    CLINICA CHIMICA ACTA, 2000, 300 (1-2) : 159 - 169
  • [37] The suppressive effects of miR-1180-5p on the proliferation and tumorigenicity of bladder cancer cells
    Ge, Qiangqiang
    Wang, Chenghe
    Chen, Zhong
    Li, Fan
    Hu, Jia
    Ye, Zhangqun
    HISTOLOGY AND HISTOPATHOLOGY, 2017, 32 (01) : 77 - 86
  • [38] Curcumin Suppresses microRNA-7641-Mediated Regulation of p16 Expression in Bladder Cancer
    Wang, Kai
    Tan, Sheng-Lan
    Lu, Qiong
    Xu, Ran
    Cao, Jian
    Wu, Shui-Qing
    Wang, Yin-Huai
    Zhao, Xiao-Kun
    Zhong, Zhao-Hui
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2018, 46 (06): : 1357 - 1368
  • [39] MiR-126-3p inhibits ovarian cancer proliferation and invasion via targeting PLXNB2
    Xiang, Guixian
    Cheng, Yan
    REPRODUCTIVE BIOLOGY, 2018, 18 (03) : 218 - 224
  • [40] Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis
    Xie, Fei
    Li, Yawei
    Wang, Miao
    Huang, Chao
    Tao, Dan
    Zheng, Fuxin
    Zhang, Hui
    Zeng, Fuqing
    Xiao, Xingyuan
    Jiang, Guosong
    MOLECULAR CANCER, 2018, 17